Abstract

Applications of vibrational spectroscopy to assess bone disease and therapeutic interventions are continually advancing, with tissue mineral and protein composition frequently investigated. Here, we used two spectroscopic approaches for determining bone composition in a mouse model (oim) of the brittle bone disease osteogenesis imperfecta (OI) with and without antiresorptive agent treatment (alendronate, or ALN, and RANK-Fc). Near-infrared (NIR) spectral analysis using a fiber optic probe and attenuated total reflection Fourier transform infrared spectroscopy (ATR FTIR) mode were applied to investigate bone composition, including water, mineral, and protein content. Spectral parameters revealed differences among the control wildtype (WT) and OIM groups. NIR spectral analysis of protein and water showed that OIM mouse humerii had ∼50% lower protein and ∼50% higher overall water content compared to WT bone. Moreover, some OIM-treated groups showed a reduction in bone water compared to OIM controls, approximating values observed in WT bone. Differences in bone quality based on increased mineral content and reduced carbonate content were also found between some groups of treated OIM and WT bone, but crystallinity did not differ among all groups. The spectroscopically determined parameters were evaluated for correlations with gold-standard mechanical testing values to gain insight into how composition influenced bone strength. As expected, bone mechanical strength parameters were consistently up to threefold greater in WT mice compared to OIM groups, except for stiffness in the ALN-treated OIM groups. Furthermore, bone stiffness, maximum load, and post-yield displacement showed the strongest correlations with NIR-determined protein content (positive correlations) and bound-water content (negative correlations). These results demonstrate that in this study, NIR spectral parameters were more sensitive to bone composition differences than ATR parameters, highlighting the potential of this nondestructive approach for screening of bone diseases and therapeutic efficacy in pre-clinical models.

© 2021 The Author(s)

Spatially offset Raman spectroscopy for in vivo bone strength prediction

Chi Shu, Keren Chen, Maria Lynch, Jason R. Maher, Hani A. Awad, and Andrew J. Berger
Biomed. Opt. Express 9(10) 4781-4791 (2018)

Cortical bone quality affectations and their strength impact analysis using holographic interferometry

Cesar G. Tavera Ruiz, Manuel H. De La Torre-Ibarra, J. M. Flores-Moreno, Claudio Frausto-Reyes, and Fernando Mendoza Santoyo
Biomed. Opt. Express 9(10) 4818-4833 (2018)

Second-harmonic generation circular dichroism studies of osteogenesis imperfecta

Xiyi Chen, Cathleen Raggio, and Paul J. Campagnola
Opt. Lett. 37(18) 3837-3839 (2012)

Photoacoustic characterization of bone physico-chemical information

Weiya Xie, Ting Feng, Dong Yu, Dean Ta, Liming Cheng, and Qian Cheng
Biomed. Opt. Express 13(5) 2668-2681 (2022)

Optimizing infrared spectral discrimination to enhance disease diagnostics: monitoring the signatures of inflammatory bowel diseases with anti-TNFα therapy

Hemendra Ghimire, Xinjie Hu, Gengsheng Qin, and A. G. Unil Perera
Biomed. Opt. Express 11(8) 4679-4694 (2020)